Skip to content
healthcare.dev

Aptiom

NDC 63402-204, ESLICARBAZEPINE ACETATE, tablet, from Sumitomo Pharma America, Inc..

Product NDC
63402-204
Status
Listed
Labeler
Sumitomo Pharma America, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022416
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63402-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESLICARBAZEPINE ACETATE400 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
63402-204-28634020204284 BLISTER PACK in 1 CARTON (63402-204-28) / 7 TABLET in 1 BLISTER PACK (63402-204-07)
63402-204-306340202043030 TABLET in 1 BOTTLE (63402-204-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3d0c9554-eaeb-4694-8089-00133fcadce3
  • NADAC price for package 63402020430

    GET /v1/drugs/nadac/63402020430

Use it

Look up 63402-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63402-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63402-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.